Raymond Keith Cross Jr. MD MS, AGAF, FACG

Inflammatory Bowel Disease

Professor of Medicine Director, IBD Program Co-Director, Digestive Health Center

685 W. Baltimore Street, Suite 8-00Baltimore, MD 21201
Phone+1 410-706-6012
Fax+1 410-706-4330

Dr. Cross is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cross' full profile Already have an account?

Education & Training

University of MarylandFellowship, Gastroenterology, 2004
University of MarylandResidency, Internal Medicine, 1997 - 2001
University of Pittsburgh School of MedicineClass of 1997

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 2000 - 2028
PA State Medical License 2020 - 2022
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013, 2015-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017

Clinical Trials

The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis
COMPLETED
PHASE3
The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
TERMINATED
PHASE2
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
COMPLETED
PHASE3

Publications & Presentations

PubMed

The Great Masquerader: When Perianal Disease Isn't What It Seems.
Cydney Nguyen, Raymond K Cross, Xiaobang Hu, Kofi Clarke
Digestive Diseases and Sciences. 2026-08-01
Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SE...
Tim Raine, Silvio Danese, Stefan Schreiber, Xiang Gao, Stephen Hanauer
Journal of Crohn's & Colitis. 2026-07-07
4 citations
Inflammatory Bowel Diseases-Specific Cognitive Behavioral Therapy Delivered Through Telehealth Reduces Disability: Addressing Disability Effectively With Psychosocial ...
Chung Sang Tse, James D Lewis, Sara N Horst, Sumona Saha, Sasha Taleban
The American Journal of Gastroenterology. 2026-06-01

Journal Articles

A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)
David A Schwartz, Mahrukh Riaz, Raymond K Cross, Seema A Patil, Sandra M Quezada, Barathi Sivasailam, Sara N Horst, Miguel Regueiro, Leyla Ghazi, Nature
Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn’s Disease
Seema A Patil, Raymond K Cross, Digestive Diseases and Sciences
Correction to: Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life
Michael D Kappelman, Swathi Eluri, Robert S Sandler, Millie D Long, Raymond K Cross, Digestive Diseases and Sciences

Authored Content

An Update on Safety of Janus Kinase Inhibitors in Treatment of Patients with IBDJune 2024
Steroids: Never or ForeverDecember 2022
A Dog Is a Child's Best FriendMay 2022

Press Mentions

Treat IBD with Confidence: Clinical Strategies That Make a DifferenceApril 30th, 2025
Raymond Cross, MD, on JAK Inhibitors in IBDApril 10th, 2025
What Is Infusion for Ulcerative Colitis?March 24th, 2025